Tag: Mubadala’s KELIX bio
Mubadala’s KELIX bio completes acquisition of DiabTec
KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar.
This acquisition...
Mubadala’s KELIX bio to acquire 4 GlobalOne Healthcare Holding assets
Mubadala Investment Company, an Abu Dhabi sovereign investor, has empowered its new specialty pharmaceutical business, KELIX bio, to acquire a 100 percent stake in...
